Due to the abovementioned mechanisms, GLP-1 receptor analogs (GLP-1RA) are often used to treat type 2 diabetes mellitus (T2DM) and obesity. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.